Berlin, Germany

Ningshu Liu

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2014-2023

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Ningshu Liu: Innovator in Cancer Therapeutics

Introduction

Ningshu Liu, based in Berlin, DE, is a prolific inventor with a remarkable portfolio of 19 patents. His work predominantly focuses on advancements in cancer treatment, particularly through innovative combinations of pharmaceutical compounds.

Latest Patents

Liu's latest patents include groundbreaking inventions such as the combinations of copanlisib with anti-PD-1 antibodies. This invention encompasses various 2,3-dihydroimidazo[1,2-c]quinazoline compounds or their acceptable derivatives, coupled with anti-Programmed Cell Death Protein 1 (anti-PD-1 mAb) antibodies. These formulations are designed for administration through multiple routes, offering potential for the treatment and prophylaxis of cancer.

Another significant patent by Liu is for 2-amino-N-[7-methoxy-2,3-dihydroimidazo-[1,2-c]quinazolin-5-yl] pyrimidine-5-carboxamides. This invention highlights novel compounds aimed at inhibiting phosphatidylinositol-3-kinase (PI3K) and treating diseases related to its activity, specifically hyper-proliferative and angiogenesis disorders.

Career Highlights

Ningshu Liu has made notable strides in his career while working with Bayer Intellectual Property GmbH and Bayer Pharma Aktiengesellschaft. His experience at these prominent companies has allowed him to contribute to significant advancements in the pharmaceutical field, particularly regarding cancer therapies.

Collaborations

Throughout his career, Liu has had the privilege of collaborating with accomplished professionals such as Ulf Bömer and Ursula Mönning. These partnerships have enriched his research endeavors, leading to innovative solutions in drug development.

Conclusion

With a total of 19 patents, Ningshu Liu stands out as a key innovator in the field of cancer treatment. His contributions, particularly in the development of new therapeutic combinations, demonstrate his commitment to advancing medical science and improving patient outcomes. As he continues to push the boundaries of pharmaceutical research, Liu’s work remains vital in the ongoing battle against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…